These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 7701191)

  • 1. Modafinil: a double-blind multicentric study.
    Billiard M; Besset A; Montplaisir J; Laffont F; Goldenberg F; Weill JS; Lubin S
    Sleep; 1994 Dec; 17(8 Suppl):S107-12. PubMed ID: 7701191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy.
    Broughton RJ; Fleming JA; George CF; Hill JD; Kryger MH; Moldofsky H; Montplaisir JY; Morehouse RL; Moscovitch A; Murphy WF
    Neurology; 1997 Aug; 49(2):444-51. PubMed ID: 9270575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placebo and modafinil effect on sleepiness in obstructive sleep apnea.
    Bittencourt LR; Lucchesi LM; Rueda AD; Garbuio SA; Palombini LO; Guilleminault C; Tufik S
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):552-9. PubMed ID: 18053628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea/hypopnea syndrome.
    Black JE; Hirshkowitz M
    Sleep; 2005 Apr; 28(4):464-71. PubMed ID: 16171291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of modafinil on symptomatology of human narcolepsy.
    Boivin DB; Montplaisir J; Petit D; Lambert C; Lubin S
    Clin Neuropharmacol; 1993 Feb; 16(1):46-53. PubMed ID: 8093681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial.
    Högl B; Saletu M; Brandauer E; Glatzl S; Frauscher B; Seppi K; Ulmer H; Wenning G; Poewe W
    Sleep; 2002 Dec; 25(8):905-9. PubMed ID: 12489899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modafinil improves alertness, vigilance, and executive function during simulated night shifts.
    Walsh JK; Randazzo AC; Stone KL; Schweitzer PK
    Sleep; 2004 May; 27(3):434-9. PubMed ID: 15164895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea: a 12-week, open-label study.
    Schwartz JR; Hirshkowitz M; Erman MK; Schmidt-Nowara W
    Chest; 2003 Dec; 124(6):2192-9. PubMed ID: 14665500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Findings of the Maintenance of Wakefulness Test and its relationship with response to modafinil therapy for residual excessive daytime sleepiness in obstructive sleep apnea patients adequately treated with nasal continuous positive airway pressure.
    Inoue Y; Miki M; Tabata T
    Sleep Med; 2016; 27-28():45-48. PubMed ID: 27938918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction in excess daytime sleepiness by modafinil in patients with myotonic dystrophy.
    Talbot K; Stradling J; Crosby J; Hilton-Jones D
    Neuromuscul Disord; 2003 Jun; 13(5):357-64. PubMed ID: 12798791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alertness and psychomotor performance effects of the histamine-3 inverse agonist MK-0249 in obstructive sleep apnea patients on continuous positive airway pressure therapy with excessive daytime sleepiness: a randomized adaptive crossover study.
    Herring WJ; Liu K; Hutzelmann J; Snavely D; Snyder E; Ceesay P; Lines C; Michelson D; Roth T
    Sleep Med; 2013 Oct; 14(10):955-63. PubMed ID: 23920422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modafinil in obstructive sleep apnea-hypopnea syndrome: a pilot study in 6 patients.
    Arnulf I; Homeyer P; Garma L; Whitelaw WA; Derenne JP
    Respiration; 1997; 64(2):159-61. PubMed ID: 9097352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea.
    Pack AI; Black JE; Schwartz JR; Matheson JK
    Am J Respir Crit Care Med; 2001 Nov; 164(9):1675-81. PubMed ID: 11719309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of modafinil on wakefulness and executive function in patients with narcolepsy experiencing late-day sleepiness.
    Schwartz JR; Nelson MT; Schwartz ER; Hughes RJ
    Clin Neuropharmacol; 2004; 27(2):74-9. PubMed ID: 15252267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of adjunctive modafinil on wakefulness and quality of life in patients with excessive sleepiness-associated obstructive sleep apnoea/hypopnoea syndrome: a 12-month, open-label extension study.
    Hirshkowitz M; Black J
    CNS Drugs; 2007; 21(5):407-16. PubMed ID: 17447828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of a new central adrenergic agonist--modafinil--and D-amphetamine on sleep and early morning behaviour in young healthy volunteers.
    Saletu B; Frey R; Krupka M; Anderer P; Grünberger J; Barbanoj MJ
    Int J Clin Pharmacol Res; 1989; 9(3):183-95. PubMed ID: 2568348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of sodium oxybate, modafinil, and combination treatment on excessive daytime sleepiness in patients who have narcolepsy with or without cataplexy.
    Black J; Swick T; Bogan R; Lai C; Carter LP
    Sleep Med; 2016 Aug; 24():57-62. PubMed ID: 27810187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modafinil in the treatment of idiopathic hypersomnia without long sleep time--a randomized, double-blind, placebo-controlled study.
    Mayer G; Benes H; Young P; Bitterlich M; Rodenbeck A
    J Sleep Res; 2015 Feb; 24(1):74-81. PubMed ID: 25196321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. US Modafinil in Narcolepsy Multicenter Study Group.
    Ann Neurol; 1998 Jan; 43(1):88-97. PubMed ID: 9450772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the treatment of the alcoholic organic brain syndrome with an alpha-adrenergic agonist modafinil: double-blind, placebo-controlled clinical, psychometric and neurophysiological studies.
    Saletu B; Saletu M; Grünberger J; Frey R; Zatschek I; Mader R
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(2):195-214. PubMed ID: 1968672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.